The Jerusalem District Court has granted AutoMax’s request to delay merger proceedings until September 30, according to an SEC filing by SciSparc. AutoMax, which specializes in manufacturing ...
On Monday, SciSparc Ltd (NASDAQ:SPRC) stock is trading higher with a session volume of 30.86 million compared to an average volume of 7.73 million as per data from Benzinga Pro. Under the ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
An announcement from SciSparc Ltd. ( (SPRC)) is now available. SciSparc Ltd., a Nasdaq-listed clinical-stage pharmaceutical developer focused on cannabinoid-based therapeutics, is advancing drug ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
SciSparc (NASDAQ:SPRC) stock is taking off on Friday as investors react to an update on its drug development joint venture. MitoCareX Bio is the joint venture behind today’s rise. MitoCareX focuses on ...
Shares of drug discovery specialist SciSparc (NASDAQ:SPRC) are popping sharply today on encouraging clinical study results. Specifically, the company’s joint venture (JV) project MitoCareX Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results